Recently added
This page was added on 04 March 2026.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
AstraZeneca
Administration route
Nasal spray
Vaccine group
People aged ≥2 to <18 years only
Description:
Registered for use in people aged ≥24 months and <18 years old
Trivalent live attenuated influenza vaccine
Each 0.2 mL divided dose pre-filled single-use nasal applicator contains:
- 107.0±0.5 FFU (fluorescent focus units) of each of the 3 recommended influenza virus strains.
- sucrose
- dibasic potassium phosphate
- monobasic potassium phosphate,
- hydrolysed gelatin (porcine Type A)
- arginine hydrochloride
- monosodium glutamate monohydrate
May contain traces of:
- ovalbumin (<0.24 µg)
- gentamicin sulfate (<0.015 µg)
For Product Information and Consumer Medicine Information about Flumist visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases